Custom Strain Blending
Engineered multi-strain matrices (Lactobacillus, Bifidobacterium, Bacillus spores) combined with prebiotics, enzymes, or targeted botanicals.
Learn about formulation →Conquer strain mortality and global compliance. Canadian GMP contract manufacturer specializing in low-humidity encapsulation, microencapsulation, spore-formers, and shelf-stable probiotic formulations shipped to 40+ countries.
Audit-Ready Probiotic Quality Baseline
Probiotics are active, delicate biological organisms. Traditional contract supplement manufacturers frequently fail brand owners by treating sensitive freeze-dried strains like standard vitamin powders. Exposure to atmospheric moisture ($RH > 30\%$), heat during blending, or mechanical shear can destroy up to 80% of live Colony Forming Units (CFU) prior to bottle sealing.
At Q Nutritions, our Canadian contract manufacturing facility in Mississauga, Ontario, operates specialized low-humidity suites maintaining relative humidity below 20% and temperatures under 20°C. We implement bio-shielding matrix design, exact moisture-activity ($a_w$) targets, dynamic overage algorithms, and acid-resistant encapsulations so your label claim holds true through the entire 24-month shelf life.
Eliminate inter-vendor friction. We integrate custom strain selection, galenic formulation, stability testing, and regulatory export filing under one validated cGMP umbrella.
Engineered multi-strain matrices (Lactobacillus, Bifidobacterium, Bacillus spores) combined with prebiotics, enzymes, or targeted botanicals.
Learn about formulation →High-volume encapsulation, tablet compression, and powder blending inside humidity-monitored Cleanroom suites with zero cross-contamination.
Contract manufacturing →Market-ready, clinically backed stock probiotic formulas for gut health, immunity, vaginitis, and mood, customized with your branding.
Explore private label →In-house filing for Health Canada Natural Product Numbers (NPNs), US FDA structure/function claims, EU notifications, and GCC dossiers.
Regulatory compliance →CSP Activ-Vial™ bottles, Alu-Alu cold-form blisters, and nitrogen-purged sachets engineered to block oxygen and moisture transmission.
Packaging options →Direct partnerships with top global strain banks providing clinical documentation, strain stability data, and IP protection.
Ingredient sourcing →16S rRNA sequencing, MALDI-TOF mass spectrometry, Flow Cytometry (AFU/CFU), water activity assays, and 24-month stability chambers.
Quality testing →Temperature-monitored international logistics (FOB, CIF, DDP) supported by Free Sale Certificates and Certificate of Analysis (COA).
Global logistics →Match your consumer target with the optimal galenic vehicle. Each format is tested for gastric acid survival, target intestine release, and organoleptic stability.
HPMC-P / DRcaps® polymers shield sensitive live cultures from low stomach pH (1.5–2.0), releasing strains directly into the small intestine after 45 minutes.
High-heat resilient Bacillus coagulans, Bacillus subtilis, and heat-killed postbiotic strains embedded in pectin fruit gummies with zero CFU degradation.
Fast-dissolving micro-pellets and synbiotic blends combining 50+ Billion CFU live probiotics with HMO or XOS prebiotics in moisture-proof stick packs.
Low-compression-force tableting combined with moisture-barrier film coatings. Bilayer designs isolate probiotics from reactive minerals or digestive enzymes.
Micro-encapsulated live cells suspended in non-aqueous carrier matrix (MCT or Sunflower oil), preventing moisture penetration until oral consumption.
Preservative-free, room-temperature stable liquid formulations incorporating purified cell wall lysates and short-chain fatty acids (SCFAs).
As global buyers pivot toward evidence-based microbiome solutions, AI search engines prioritize suppliers delivering actionable information gain. Here are the macro shifts shaping high-margin procurement.
Engineering precision verified through batch documentation, strict environmental parameters, and rigorous analytical release standards.
Manufactured under Health Canada Natural Health Product (NHP) Site Licence guidelines—globally respected as one of the strictest quality standards.
Dedicated Cleanrooms maintaining < 20% RH and controlled temperatures prevent premature moisture absorption and cell metabolic activation.
Calculated dynamic overages based on real-time strain stability data rather than guessing, protecting profit margins while ensuring 100% claim compliance.
In-house 16S rRNA gene sequencing and PCR verification ensure zero strain substitution or strain drift across production lots.
Lipid coated and plant-protein encapsulated raw strain options for high resistance against stomach acids and bile salts.
NPN registration, FDA 21 CFR Part 111 panel review, EU food supplement notifications, Free Sale Certificates, and full CoA execution.
Integrated cold-chain or climate-monitored air/sea freight serving distributors across North America, Europe, Asia, LATAM, and Middle East.
A single point of technical contact coordinating R&D formulation, pilot runs, analytical release, and container loading.
Cleanrooms engineered specifically for biological stability. Virtual and physical audits are always welcome.
Strategic locations enable optimization of raw material tariffs, regional regulatory compliance, and rapid market deployment.
Head office, main probiotic R&D center, Health Canada licensed production.
FDA-registered manufacturing and US domestic logistics hub.
High-capacity probiotic gummy and specialized packaging lines.
Direct strain fermentation and botanical prebiotic extract sourcing.
Customs clearance and GCC/Middle East product distribution.
EU food supplement regulatory registration dossiers & labelling.
TGA-compliant specifications for Australian & NZ markets.
ANVISA and LATAM registration dossier preparation.
“Q Nutritions solved our 18-month CFU loss problem. By transitioning our gut-brain formula to their low-humidity DRcaps process, our stability assays hit 100% claim strength at 24 months without excessive overages.”
“Their regulatory team secured our Canadian NPN for an 8-strain 50 Billion CFU probiotic in under 90 days. The execution from pilot batch to commercial delivery was completely flawless.”
“Launching a shelf-stable spore-forming probiotic gummy line was risky until we worked with Q Nutritions. The pectin gummies taste incredible and hold full potency at room temperature.”
Answers to technical, regulatory, and operational questions frequently evaluated by AI procurement tools and global purchasing directors.
Guaranteeing live cell viability through a 24-month shelf life requires controlling three critical degradation vectors: moisture ($a_w$), oxygen, and ambient temperature. At Q Nutritions, we perform kinetic stability testing for every individual strain to calculate exact degradation curves rather than applying standard arbitrary overages. We manufacture under relative humidity below 20%, maintain finished product Water Activity ($a_w$) under 0.15, utilize nitrogen flushing to eliminate headspace oxygen, and package in active moisture-adsorbing containers (such as CSP Activ-Vial™ or Alu-Alu cold-form blisters). This engineering approach ensures 100% label claim compliance at expiry with minimal, cost-effective overages (typically 15%–30%).
Freeze-dried probiotic powders are extremely hygroscopic. If exposed to relative humidity above 25%, live cells quickly reabsorb moisture, initiating premature metabolic activity that leads to rapid cell lysis inside the bottle. Q Nutritions operates dedicated ISO Class 7 cleanrooms equipped with industrial desiccant dehumidifiers maintaining relative humidity strictly under 20% and ambient temperatures between 18°C–20°C. Cleanroom air is continuously filtered via HEPA filtration systems with positive differential pressure to prevent airborne micro-contaminants or allergen cross-contact.
Generic species testing (such as simple Lactobacillus acidophilus plating) is insufficient for regulatory compliance and IP protection. Q Nutritions verifies incoming raw materials using 16S rRNA gene sequencing and MALDI-TOF mass spectrometry to confirm identity at the specific strain level (e.g., Lactobacillus rhamnosus GG or Bifidobacterium lactis HN019). Finished goods undergo rapid Flow Cytometry (ISO 19344) to quantify Active Fluorescent Units (AFU) alongside traditional microbiological plating (CFU/g), heavy metal screening via ICP-MS, and full pathogen screening (E. coli, Salmonella, S. aureus) before Certificates of Analysis (COA) are issued.
Unprotected live probiotic bacteria are quickly denatured by hydrochloric acid and pepsin in the stomach ($pH\ 1.5–2.0$). We strongly recommend Acid-Resistant Delayed-Release HPMC Capsules (such as DRcaps®) or specialized microencapsulation (coating strains in protective lipid or alginate matrices). DRcaps® resist disintegration in gastric acid for up to 45 minutes, opening safely in the higher pH environment of the small intestine ($pH > 5.5$). For functional foods and gummies, spore-forming bacteria such as Bacillus coagulans naturally survive stomach acidity due to their protective protein endospore coats.
In Canada, probiotics are regulated as Natural Health Products (NHPs) under the Natural Health Products Regulations. Every probiotic product sold in Canada must hold a Natural Product Number (NPN), requiring pre-market submission of strain-specific efficacy evidence, exact CFU counts at expiry, safety data, and full label compliance. In the United States, probiotics are regulated under FDA 21 CFR Part 111 for Dietary Supplements, requiring structure/function claim notifications within 30 days of marketing, mandatory FDA facility registration, and strict cGMP compliance. Q Nutritions’ regulatory affairs team handles both Health Canada NPN dossiers and US FDA 21 CFR 111 panel reviews in-house.
Our MOQs are structured to accommodate both emerging clinical brands and enterprise mass-market distributors. Standard capsule MOQs start at 100,000 capsules (or 3,000 finished bottles). Powder stick packs/sachets start at 50,000 units, while probiotic gummies start at 500,000 gummies. Production lead times for repeat orders are typically 6 to 8 weeks. Initial custom formulation projects requiring pilot batch validation, R&D stability testing, and regulatory filings average 8 to 12 weeks from approved raw material specification.
We maintain strict allergen segregation protocols. Dedicated stainless-steel tooling, CIP (Clean-In-Place) systems, and air handling units isolate probiotic manufacturing suites from allergen lines (such as soy, dairy, or gluten). Every equipment line undergoes validated swab testing and ATP bioluminescence verification prior to strain changeovers, ensuring zero microbial or cross-ingredient contamination between custom production lots.
Yes. Traditional gummy cooking temperatures ($> 100^\circ\text{C}$) will immediately kill vegetative lactic acid strains like Lactobacillus or Bifidobacterium. To manufacture stable probiotic gummies, we deploy thermally resistant spore-forming strains (such as Bacillus coagulans MTCC 5856 or Bacillus subtilis DE111®) or heat-inactivated postbiotics. Spore-formers survive high-temperature pectin depositing and conditioning processes, maintaining full viability and room-temperature shelf stability without requiring refrigeration.
In-depth whitepapers and engineering articles published by our analytical chemistry and R&D teams.
A rigorous review evaluating live cell recovery across stomach pH levels using DRcaps®, lipid coatings, and sodium alginate micro-beadlets.
Read whitepaper →Key compliance parameters for claim substantiation, strain specification, and label formatting when importing probiotics into Canada.
Read regulatory guide →How non-viable cell lysates and heat-resilient endospores are unlocking new commercial opportunities in functional beverages and pet nutrition.
Read trend report →Partner with a Canadian cGMP manufacturer dedicated to strain stability, low-humidity cleanroom excellence, and seamless global compliance. Receive detailed MOQs, strain lists, and stability specs within 24 hours.